Growth Metrics

Resmed (RMD) Cash from Investing Activities (2016 - 2025)

Resmed's Cash from Investing Activities history spans 17 years, with the latest figure at -$50.9 million for Q4 2025.

  • For Q4 2025, Cash from Investing Activities fell 38.84% year-over-year to -$50.9 million; the TTM value through Dec 2025 reached -$269.0 million, down 135.55%, while the annual FY2025 figure was -$200.0 million, 25.85% up from the prior year.
  • Cash from Investing Activities reached -$50.9 million in Q4 2025 per RMD's latest filing, up from -$52.6 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $2.1 million in Q3 2024 to a low of -$1.0 billion in Q4 2022.
  • Average Cash from Investing Activities over 5 years is -$103.5 million, with a median of -$48.8 million recorded in 2021.
  • Peak YoY movement for Cash from Investing Activities: surged 101.44% in 2024, then plummeted 2550.05% in 2025.
  • A 5-year view of Cash from Investing Activities shows it stood at -$83.3 million in 2021, then plummeted by 1132.07% to -$1.0 billion in 2022, then soared by 95.99% to -$41.1 million in 2023, then increased by 10.82% to -$36.7 million in 2024, then plummeted by 38.84% to -$50.9 million in 2025.
  • Per Business Quant, the three most recent readings for RMD's Cash from Investing Activities are -$50.9 million (Q4 2025), -$52.6 million (Q3 2025), and -$133.7 million (Q2 2025).